Skip to main content
. 2012 Nov 16;22(4):696–703. doi: 10.1093/hmg/dds477

Table 2.

CYP26C1 Sanger sequencing results in this family and other FFDD type IV patients

Family memberd Affected CYP26C1 exon 4 CYP26C1 exon 6
I-2 No +a/c.844_851dupCCATGCAb +/+
I-3 No +/+ +/c.1433A>Gc
II-1 No +/+ +/+
II-2 No +/c.844_851dupCCATGCA +/+
II-3 Yes +/c.844_851dupCCATGCA +/ c.1433A>G
II-4 Yes +/c.844_851dupCCATGCA +/ c.1433A>G
II-5 No +/c.844_851dupCCATGCA +/+
Patient 3, this paper (3) Yes c.844_851dupCCATGCA/c.844_851dupCCATGCA +/+
Patient 4, this paper (3) Yes c.844_851dupCCATGCA/ c.844_851dupCCATGCA +/+
Patient 5, this paper Yes c.844_851dupCCATGCA/ c.844_851dupCCATGCA +/+

a+Wild type; c.844_851dupCCATGCA.

bc.844_851dupCCATGCA, predicting p.Glu284fsX128; c.1433G>A.

cc.1433A>G, predicting p.Arg478His.

dFor family pedigree information, please see Materials and Methods, exome sequencing.